Kaipeen E. Yang

Array ( [id] => 9286395 [patent_doc_number] => 08642725 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Process for production of peptide thioester' [patent_app_type] => utility [patent_app_number] => 13/379832 [patent_app_country] => US [patent_app_date] => 2010-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9291 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13379832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166691 [patent_doc_number] => 08592367 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Nodule specific medicago peptides having antimicrobial activity and pharmaceutical compositions containing the same' [patent_app_type] => utility [patent_app_number] => 13/378067 [patent_app_country] => US [patent_app_date] => 2010-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 58 [patent_no_of_words] => 22909 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9524105 [patent_doc_number] => 08748369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Use of targeted nitroxide agents in bone healing' [patent_app_type] => utility [patent_app_number] => 13/320999 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 37 [patent_no_of_words] => 31091 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772223 [patent_doc_number] => 08426176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Synthetic microcarriers for culturing cells' [patent_app_type] => utility [patent_app_number] => 12/788942 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 12812 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12788942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199287 [patent_doc_number] => 20120122785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'COMBINATION OF A LEUCINE SOURCE AND AN OMEGA- 3 UNSATURATED FATTY ACID SOURCE FOR USE IN THE TREATMENT OF HYPERCALCAEMIA' [patent_app_type] => utility [patent_app_number] => 13/322730 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9575 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122785.pdf [firstpage_image] =>[orig_patent_app_number] => 13322730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11794126 [patent_doc_number] => 09403876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Cyclic-GluR6 analogs, methods of treatment and use' [patent_app_type] => utility [patent_app_number] => 13/320848 [patent_app_country] => US [patent_app_date] => 2010-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7136 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807777 [patent_doc_number] => 08445429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Lactoferrin and neuronal health and development in the infant gut' [patent_app_type] => utility [patent_app_number] => 13/319655 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6647 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465609 [patent_doc_number] => 20120270777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'LACTOFERRIN AND GUT NEURONAL HEALTH IN ADULTS AND/OR ELDERLY' [patent_app_type] => utility [patent_app_number] => 13/319656 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6110 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9009360 [patent_doc_number] => 08524658 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Lactoferrin and brain health and development in infants' [patent_app_type] => utility [patent_app_number] => 13/319661 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8750 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8883632 [patent_doc_number] => 20130156817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'SURFACE IMMOBILIZED CHAPERONES' [patent_app_type] => utility [patent_app_number] => 13/582840 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2748 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265839 [patent_doc_number] => 20120165271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'METHODS OF TREATING RETINITIS PIGMENTOSA' [patent_app_type] => utility [patent_app_number] => 13/203293 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5003 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13203293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6514385 [patent_doc_number] => 20100216726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Substituted-Quinoxaline-Type Piperidine Compounds and the Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/712042 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 118137 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216726.pdf [firstpage_image] =>[orig_patent_app_number] => 12712042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511381 [patent_doc_number] => 20110257091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'INSULIN ANALOGS' [patent_app_type] => utility [patent_app_number] => 13/130976 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11310 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257091.pdf [firstpage_image] =>[orig_patent_app_number] => 13130976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483790 [patent_doc_number] => 20120283196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'BETA-HAIRPIN PEPTIDOMIMETICS' [patent_app_type] => utility [patent_app_number] => 13/513550 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48592 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580862 [patent_doc_number] => 20110294745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'SOLUTIONS OF LIPOPHILIC SUBSTANCES, ESPECIALLY MEDICINAL SOLUTIONS' [patent_app_type] => utility [patent_app_number] => 13/130361 [patent_app_country] => US [patent_app_date] => 2009-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4437 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294745.pdf [firstpage_image] =>[orig_patent_app_number] => 13130361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670070 [patent_doc_number] => 20110319339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'NEUROTENSIN-DERIVED BRANCHED PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/127346 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5826 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13127346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064396 [patent_doc_number] => 20110201642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Bioactive Compounds' [patent_app_type] => utility [patent_app_number] => 13/126292 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14258 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201642.pdf [firstpage_image] =>[orig_patent_app_number] => 13126292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8221715 [patent_doc_number] => 20120135914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'ETOPOSIDE AND DOXORUBICIN CONJUGATES FOR DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/124022 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 29374 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615007 [patent_doc_number] => 20100099649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'SITE-SPECIFIC CHEMICAL MODIFICATION OF PROTEINS AT THEIR N-TERMINI, ENABLING THE FORMATION OF HOMOGENEOUS ADDUCTS' [patent_app_type] => utility [patent_app_number] => 12/573860 [patent_app_country] => US [patent_app_date] => 2009-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19433 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099649.pdf [firstpage_image] =>[orig_patent_app_number] => 12573860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186522 [patent_doc_number] => 20120115793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'PEPTIDOMIMETIC MACROCYCLES' [patent_app_type] => utility [patent_app_number] => 13/120386 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25618 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115793.pdf [firstpage_image] =>[orig_patent_app_number] => 13120386 [rel_patent_id] =>[rel_patent_doc_number] =>)